Abstract：
OBJECTIVE: This study aims to explore the clinical value of autogenous tibial periosteal bone grafting in the treatment of osteochondral lesions of the talus (OLT) and analyze the three-dimensional factors in the necrotic zone of the talus.
METHODS: A retrospective analysis was performed on 36 patients who underwent autogenous tibial periosteal bone grafting in the Foot and Ankle Surgery Department of our hospital between September 2018 and September 2022. The American Orthopaedic Foot and Ankle Society (AOFAS), Visual Analogue Scale (VAS), and Chinese Short-Form 36 Health Survey (SF-36) were used to evaluate treatment efficacy prior to surgery and at the last follow-up. Furthermore, Mimics 21.0 software was employed to measure the three-dimensional data of the necrotic area, including surface area, volume, and depth, in order to investigate their potential impact on patient prognosis.
RESULTS: Among the 36 OLT patients who obtained complete follow-up, there were 22 males and 14 females. No complications such as surgical site infection, non-union of cartilage, post-traumatic arthritis, or donor site pain were observed. The AOFAS, VAS, and Chinese SF-36 scores of all patients at the last follow-up showed significant improvement compared to preoperative values. There was no significant correlation between the AOFAS, VAS, and Chinese SF-36 scores at the last follow-up and the depth, surface area, and volume of the necrotic zone.
CONCLUSIONS: The use of autogenous tibial periosteal bone grafting can safely and effectively treat Hepple V OLT. Additionally, there is no significant correlation between the three-dimensional factors of the necrotic area and the prognosis of the patients.
METHODS: A retrospective analysis was performed on 36 patients who underwent autogenous tibial periosteal bone grafting in the Foot and Ankle Surgery Department of our hospital between September 2018 and September 2022. The American Orthopaedic Foot and Ankle Society (AOFAS), Visual Analogue Scale (VAS), and Chinese Short-Form 36 Health Survey (SF-36) were used to evaluate treatment efficacy prior to surgery and at the last follow-up. Furthermore, Mimics 21.0 software was employed to measure the three-dimensional data of the necrotic area, including surface area, volume, and depth, in order to investigate their potential impact on patient prognosis.
RESULTS: Among the 36 OLT patients who obtained complete follow-up, there were 22 males and 14 females. No complications such as surgical site infection, non-union of cartilage, post-traumatic arthritis, or donor site pain were observed. The AOFAS, VAS, and Chinese SF-36 scores of all patients at the last follow-up showed significant improvement compared to preoperative values. There was no significant correlation between the AOFAS, VAS, and Chinese SF-36 scores at the last follow-up and the depth, surface area, and volume of the necrotic zone.
CONCLUSIONS: The use of autogenous tibial periosteal bone grafting can safely and effectively treat Hepple V OLT. Additionally, there is no significant correlation between the three-dimensional factors of the necrotic area and the prognosis of the patients.
摘要：
目的：本研究旨在探讨自体胫骨骨膜植骨治疗距骨软骨损伤（OLT）的临床价值，并分析距骨坏死区的三维因素。
方法：回顾性分析2018年9月至2022年9月在我院足踝外科行自体胫骨骨膜植骨的36例患者的临床资料。美国骨科足踝协会（AOFAS），视觉模拟量表(VAS),和中国简表36健康调查（SF-36）用于评估手术前和最后一次随访时的治疗效果。此外，模拟21.0软件测量坏死区域的三维数据，包括表面积，volume,和深度,为了研究它们对患者预后的潜在影响。
结果：在获得完整随访的36例OLT患者中，有22名男性和14名女性。无手术部位感染等并发症,软骨不愈合，创伤后关节炎,或供体部位疼痛观察。AOFAS,VAS,末次随访时所有患者的中国SF-36评分与术前相比均有显著改善。AOFAS之间无显著相关性,VAS,以及中国SF-36在最后一次随访和深度的分数，表面积,和坏死区的体积。
结论：使用自体胫骨骨膜植骨可以安全有效地治疗HeppleVOLT。此外,坏死区的三维因素与患者预后无显著相关性。
方法：回顾性分析2018年9月至2022年9月在我院足踝外科行自体胫骨骨膜植骨的36例患者的临床资料。美国骨科足踝协会（AOFAS），视觉模拟量表(VAS),和中国简表36健康调查（SF-36）用于评估手术前和最后一次随访时的治疗效果。此外，模拟21.0软件测量坏死区域的三维数据，包括表面积，volume,和深度,为了研究它们对患者预后的潜在影响。
结果：在获得完整随访的36例OLT患者中，有22名男性和14名女性。无手术部位感染等并发症,软骨不愈合，创伤后关节炎,或供体部位疼痛观察。AOFAS,VAS,末次随访时所有患者的中国SF-36评分与术前相比均有显著改善。AOFAS之间无显著相关性,VAS,以及中国SF-36在最后一次随访和深度的分数，表面积,和坏死区的体积。
结论：使用自体胫骨骨膜植骨可以安全有效地治疗HeppleVOLT。此外,坏死区的三维因素与患者预后无显著相关性。
